Mind Medicine (MindMed) Inc. (MNMD) filed an 8-K on October 29, 2025, confirming the pricing and closing of a public underwritten offering of common stock pursuant to its effective Form S-3 shelf registration. The company is designated as an Emerging Growth Company.
The offering involved the sale of 18,375,000 firm Common Shares at a public offering price of \(12.25 per share. Underwriters, led by Jefferies, Leerink, and Evercore, exercised their option in full to purchase an additional 2,756,250 shares. The expected net proceeds are approximately \)242.8 million, with a target closing date of
...